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Spinal cord complications after thoracic aortic
surgery: Long-term survival and functional status
varies with deficit severity
Mark F. Conrad, MD, Jason Y. Ye, BS, Thomas K. Chung, MA, J. Kenneth Davison, MD,
and Richard P. Cambria, MD, Boston, Mass
Objective: Paraplegia after thoracoabdominal aneurysm (TAA) repair has been associated with poor survival. Little
information exists concerning the spectrum of severity that characterizes spinal cord ischemic (SCI) complications. This
study stratified SCI by deficit severity to determine its impact on late survival and functional outcomes.
Methods: A review of our prospectively maintained thoracic aortic database was performed from May 1987 through
December 2005 to identify patients who experienced SCI of any extent after TAA repair. During this period, 576 patients
underwent descending thoracic aortic repair (93 open, 105 endovascular [TEVAR]) or open TAA repair (279 extent I to
III; 99 extent IV). To stratify severity of SCI, we created a spinal cord ischemia deficit (SCID) scale, which is defined as:
I, flaccid paralysis; II, average neurologic muscle grade indicating <50% function; and III, average neurologic muscle
grade indicating >50% function. Long-term outcomes were evaluated in relation to these groups by actuarial methods.
Results: During the study period, 64 (11.1%) patients developed SCI of any severity (7 of 105 [6.6%] TEVAR, 57 of 471
[12%] open). These were stratified by SCID level: I, 24 (37.5%); II, 31 (48.4%); and III, 9 (14.1%). SCI was immediate
in 33 (54.1%) and delayed in 28 (45.9%). Most SCI (6 of 7) associated with TEVAR was delayed. The 30-day mortality
was significantly higher in the SCI group than the overall patient cohort (15 of 64 [23.4%] vs 41 of 512 [8%], P < .001)
and varied by SCID level: I, 11 of 24 (45.8%); II, 4 of 31 (12.9%); and III, 0 of 9 (0%; P  .001). The 5-year actuarial
survival for all SCI was lower than for non-SCI patients (25%  6% vs 51%  3%, P < .001) and varied linearly with SCID
level but was similar between SCID II/III and the non-SCI patients (41%  10% vs 51%  3%, P  .281). No SCID I
patients were alive at 5 years. No patients with SCID I recovered the ability to walk, but eight of 11 (73%) with SCID II
and the nine (100%) with SCID III could ambulate with or without assistance at last follow-up.
Conclusion: Survival and functional outcomes correlate with SCI severity. Patients with SCID I have a poor long-term
outlook. Survival of SCID II/III patients is similar to non-SCI patients; most recover the ability to ambulate. ( J Vasc
Surg 2008;48:47-53.)Spinal cord ischemia (SCI) remains a potentially devas-
tating complication of thoracic aneurysm (TA) and thora-
coabdominal aneurysm (TAA) repair, with an overall inci-
dence of 16% in the Crawford benchmark series.1 Various
surgical and medical adjuncts, including epidural cooling,
cerebrospinal fluid drainage, systemic hypothermia, endor-
phin receptor blockade, and a variety of pharmacologic
adjuncts have been used with varying degrees of success,
leading to a significant reduction in the incidence of SCI.2-5
Despite these advances, however, SCI continues to compli-
cate central aortic surgery, affecting a minimum of 5% to
10% of patients; even in the hands of experts.5-8
A variety of reports have documented the major nega-
tive impact on short- and long-term survival in patients who
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also recognized that the spectrum of SCI includes incom-
plete deficits, including transient, totally reversible, and
sometimes unilateral leg weakness.11,12 Indeed, little infor-
mation exists concerning the spectrum of SCI complica-
tions and their respective late outcomes. In addition, the
increased application of endovascular aortic repair to the
thoracic aorta (TEVAR) has the apparent potential to di-
minish the overall risk of SCI.13 The goal of the present
study is to stratify SCI deficit severity after TA/TAA repair
in an effort to determine differences in late survival and
functional outcome.
METHODS
We prospectively collected relative clinical and demo-
graphic data throughout the study interval of May 15, 1987
to December 30, 2005. A review of this database identified
576 patients who underwent descending TA or TAA repair
during this interval and included those who underwent
elective and emergency repair. The distribution of proce-
dures was 93 (16%) open descending thoracic, 105 (18%)
endovascular descending thoracic, 279 (49%) open type I
to III thoracoabdominal, and 99 (17%) open type IV
thoracoabdominal.
The medical records of all patients who were identified
to have a neurologic deficit, regardless of the cause, were
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deficits that resulted from verified strokes and patients who
developed a neurologic deficit related either to prior sur-
gery or resulting spontaneously from thoracic pathology
before undergoing surgery. The 64 patients (11%) who
were identified that developed a lower extremity neurologic
deficit attributable to SCI after TA/TAA repair comprise
the study cohort.
It has been our practice to awaken patients in the
immediate postoperative period in the operating room to
obtain a gross motor neurologic examination and establish
a neurologic baseline. Thus, the onset of neurologic deficit
was considered immediate if it was present at this initial
examination and delayed if the deficit occurred after a
period of normal function. The Institutional Review Board
of the Massachusetts General Hospital approved this pro-
tocol, and individual consent was waived.
Preoperative and intraoperative variables as well as peri-
operative outcomes were prospectively compiled during
the study period. Chronic obstructive pulmonary disease
(COPD) was determined by preoperative pulmonary func-
tion tests, which were obtained on most patients. Urgent
operation was defined as either rupture or presentation
with acute aortic syndrome necessitating invasive monitor-
ing in the intensive care unit (ICU) and operative repair
48 hours of admission. Renal insufficiency was defined as
a serum creatinine level 1.5 mg/dL.
Spinal cord ischemia deficit. All patients who were
suspected by the surgical team to have a neurologic deficit
postoperatively underwent immediate clinical evaluation by
a neurologist. In an effort to stratify the severity of SCI after
descending TA and TAA repair, a spinal cord ischemia
deficit (SCID) scoring system was established. This is based
upon a modification of the American Spinal Injury Associ-
ation (ASIA) impairment classification that uses standard
neurologic muscle scores (range, 0-5) for three levels of
motion, including the hip (extensor, flexor, abductor and
adductor), knee (extensor and flexor), and foot (dorsiflexor
and plantar flexor muscles).14,15
The documented physical findings of the neurologist
and functional impairment/ability documented by physical
therapists were used to assign a score to each patient that
was averaged across the three levels to establish an overall
functional score of 0 to 5. Patients who averaged 0 to 1
were assigned to SCID category I, which corresponds with
an ASIA A classification and represents flaccid paralysis.
Patients with an average score of 1 to 3 were assigned to
SCID category II, which represents an average neurologic
muscle grade that indicates 50% function (ASIA B and
C). Patients with an average score 3 were assigned to
SCID category III, indicating 50% muscle function
(ASIA D). ASIA E patients have normal function and were
not included in the SCID classification. Documented neu-
rologic muscle grades were not available for four patients,
all of whom had flaccid paralysis immediately postopera-
tively and subsequently died before a meaningful neuro-logic examination could be performed. These patients were
assigned to SCID category I based on the immediate
postoperative examination of the operating surgeon.
Operative conduct. The clamp and sew technique,
with or without neuroprotective adjuncts, was used in 92%
of open cases. Distal aortic perfusion was reserved for
patients with an anticipated technically complex proximal
anastomosis or significant renal insufficiency.
Epidural cooling has been used for spinal cord protec-
tion at our institution since July 1993 (types I to III TAA)
and, when implemented, was supervised in all cases by a
dedicated vascular anesthesia team. Epidural cooling was
used in all elective type I to III TAA repairs after 1993 but
was not routinely used in patients with type IV TAA. In
addition, patients who were considered to be too hemody-
namically unstable to have a drain placed did not receive
epidural cooling.
Details of the clamp and sew technique and the epidural
infusion system have been previously reported.2,16,17 In
brief, the epidural cooling system uses an iced saline epi-
dural infusion, which provides for moderate (25° to 27° C)
hypothermia to the spinal cord during the critical period
when the aorta is cross-clamped. Patent intercostals vessels
in the T9 to L1 region were reimplanted by means of a
separate inclusion button or were preserved with a beveled
anastomosis, when technically feasible. After reperfusion of
the lower extremities, epidural cooling was discontinued,
and continuous passive cerebrospinal fluid drainage to keep
cerebrospinal fluid pressure at 10 mmHg was initiated and
continued for 48 hours.
Clinical end points. The primary end points of this
study included perioperative mortality, long-term survival,
and overall functional outcome measured by ambulatory
status. Perioperative mortality was defined as any death
30 days of the procedure or any death occurring during
the initial hospitalization. Early and long-term functional
status and survival was determined by a review of office
charts and the hospital’s computerized medical record.
Ambulatory status was classified into three categories for
ease of data collection that included: (1) wheelchair bound,
(2) ambulatory with assistance (walker/cane), and (3) am-
bulatory without assistance. Patients who were last known
to be alive but had not been seen in more than a year were
queried in the Social Security Death Index database to
ensure an accurate account of current survival status.
A secondary end point included perioperative morbid-
ity, defined as:
● Major pulmonary complications: mechanical ventila-
tion 72 hours postoperatively, reintubation, respira-
tory failure requiring ICUmonitoring, pneumonia, or
need for tracheostomy.
● Significant renal failure: postoperative serum creati-
nine levels3.0 mg/dL in patients with normal base-
line levels or need for dialysis.
● Cardiac complications: myocardial infarction (MI) as
confirmed by electrocardiogram, and appropriate lab-
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tervention.
● Gastrointestinal complications, including bleeding ep-
isodes.
● Strokes, which were confirmed using appropriate im-
aging techniques.
Statistical analysis. Data were analyzed using 2 or
Fisher exact tests, as appropriate, for nominal variables. The
Student t and Wilcoxon tests were used to assess continu-
ous variables. A multivariate logistic regression model was
created to analyze differences between patients who expe-
rienced SCI and those who did not. Long-term survival was
determined using Kaplan-Meier life-table methods. Values
of P  .05 were considered significant.
RESULTS
The study cohort consisted of 64 patients who experi-
enced SCI of any severity after TA/TAA repair. The clinical
and demographic features of patients with SCI are com-
Table I. Demographic and clinical data for 576 patients
undergoing descending thoracic and thoracoabdominal
repair
Variable SCI No SCI P
Patients, No. 64 512
Age, mean  SD years 74  7.9 71  11.3 .09
Male sex, No. (%) 27 (42) 265 (52) .13
Diabetes mellitus, No. (%) 5 (8) 41 (8) .97
Hypertension, No. (%) 59 (92) 446 (87) .29
Smoker (former or
current), No. (%) 49 (77) 400 (78) .74
Serum creatinine (1.5
mg/dL), No. (%) 15 (23) 106 (21) .54
CAD by history or ECG,
No. (%) 54 (84) 276 (54) .001
Family history, No. (%) 4 (6) 41 (8) .62
Max aneurysm diameter,
mean  SD, cm 7.2  1.7 6.7  1.5 .01
Dissection, No. (%) 15 (23) 57 (15) .09
CAD, Coronary artery disease; ECG, electrocardiography; SCI, spinal cord
ischemia.
Table II. Incidence of spinal cord ischemia stratified by
aneurysm extent
Aneurysm extent SCI, no (%)
Descending thoracic
Open, No (%) 7/93 (7)
TEVAR, No (%) 7/105 (7)
Thoracoabdominal
Type I, No (%) 14/58 (24)
Type II, No (%) 13/65 (20)
Type III, No (%) 21/156 (13)
Type IV, No (%) 2/99 (2)
SCI, Spinal cord ischemia; TEVAR, thoracic endovascular aneurysm repair.pared with those of patients without SCI in Table I. Amultivariate regression model was created, and only aneu-
rysm size remained significant (coefficient  1.255, 95%
confidence interval, 1.033-1.524, P  .02). The incidence
of SCI varied by aneurysm extent, as detailed in Table II. In
the SCI cohort, 57 patients (89%) underwent open aneu-
rysm repair and the remaining 7 (11%) were treated with
TEVAR. Neuroprotective operative adjuncts of any nature
were used in 41 patients (64%), and the combination of
cerebrospinal fluid drainage and epidural cooling was ap-
plied to 27 (42%). The average total aortic cross-clamp time
was 85.9  31.2 minutes, and intraoperative hypotension
was documented in 16 patients (25%).
The average ICU length of stay in patients with SCI
was 9 days (range, 0-52 days), and the average hospital
length of stay was 25 days (range, 0-120 days). All patients
experienced postoperative complications in addition to
SCI, which are summarized in Table III. Patients were
stratified by severity of neurologic deficit and assigned to
the following groups: SCID I, 24 (38%); SCID II, 31
(48%); and SCID III, 9 (14%). Predictors of SCID score are
detailed in Table IV.
SCI deficit was immediate in 27 patients (42%) and had
a delayed presentation in the remaining 37 (58%). There
was no difference in timing of presentation with respect to
SCID score (SCID I: immediate 52% vs delayed 36%; SCID
II/III: immediate 48% vs delayed 64%; P  .11) or use of
neuroprotective adjunct (immediate, 41% vs delayed, 59%;
P .14). Six of seven (85%) TEVAR patients with SCI had
a delayed presentation, whereas 25 of 57 (44%) who had
open surgery presented in the same manner (P  .03).
Timing of presentation had no impact on perioperative
mortality (immediate, 18% vs delayed, 30%; P  .10).
Perioperative mortality was 23% (15 of 64) in the SCI
group, which was significantly higher than the 8% (41 of
512) seen in those without SCI (P  .001). When the
perioperative mortality was stratified by SCID classifica-
tion, there was a significant difference across the groups.
Mortality was highest in those with SCID I deficits, at 46%
(11 of 24), was 13% (4 of 31) in those with SCID II, and 0%
in the remaining patients with SCID III lesions (P .001).
A small number of patients did show improvement in
their functional outcome while hospitalized, and seven
(11%) had fully recovered neurologic function at the time
of discharge. The average follow-up was 27 months. Ex-
Table III. Additional postoperative complications seen
in 64 patients with spinal cord ischemia
Complication No. (%)
Pulmonary 38 (59)




Epidural hematoma 3 (5)cluding patients who died during the perioperative period,
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patient (either current or before death), with 61% confined
to a wheelchair, 9% ambulating with assistance, and the
remaining 30% ambulating independently. When ambula-
tory status was stratified by SCID, 0% of SCID I were
ambulatory, whereas 73% of SCID II and 100% of SCID III
had recovered ambulatory status, with or without assis-
tance, during follow-up.
Long-term all-cause survival was calculated using
Kaplan-Meier life-table methods. The 5-year survival for all
patients with SCI was 25%  6%, which was significantly
lower than those without SCI (51% 3%, P .001; Fig 1).
When those without SCI were compared with patients with
SCID II and III deficits, the curves were essentially the
same (5-year survival of SCID II and III was 41% 9%, P
.281). Finally, as expected, the survival of patients with
SCID I deficits was significantly lower than patients in the
SCID II and III groups, at 0% vs 41% at 5 years (P .001;
Fig 2).
DISCUSSION
The benchmark report by Crawford et al18 of their
experience with 1500 patients treated during the interval
1960 to 1991 established the incidence of SCI after TA/
Table IV. Analysis of variables predicting immediate






SCID II & III
(n  40)
Age 75 years 42 65 .07
Male sex 63 30 .01
Diabetes 4 10 .40
History of smoking 77 80 .84
Hypertension 92 93 .90
COPD 38 30 .54
History of DVT 8 5 .59
PVD 21 20 .94
History of MI 8 15 .43
History of CVA/TIA 25 10 .11
Family history 4 8 .59
Hyperlipidemia 25 30 .67
CAD 88 83 .59
Renal insufficiency 26 8 .04
Open descending 13 10 .76
TEVAR descending 13 10 .76
Type I TAA 8 30 .03
Type II TAA 29 15 .18
Type III TAA 29 35 .63
Type IV TAA 8 0 .06
Spinal drain  EC 26 53 .04
Any spinal adjunct 60 78 .14
Aneurysm 7 cm 61 68 .64
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease; CVA, cerebrovascular accident; DVT, deep vein thrombosis; EC,
epidural cooling; PVD, peripheral vascular disease; SCID, spinal cord isch-
emia deficit; TIA, transient ischemic attack; TAA, thoracoabdominal aneu-
rysm; TEVAR, thoracic endovascular aneurysm repair.TAA repair to be 16%. The addition of a variety of adjunc-tive strategies designed to minimize SCI have led to rather
consistent results of 5% to 10% in contemporary series.7,8,10
SCI remains a formidable obstacle despite these improved
results, and fewwould suggest that SCI is a solved problem.
Indeed, in the current study, the overall incidence of SCI of
any severity was 11% (includes emergency cases). There is
consensus with respect to the clinical variables that influ-
ence the risk of SCI during TA/TAA repair, but because
this is not the focus of this report, these are reviewed
elsewhere.2,7,8,10,19,20
The predominant cause of SCI is thought to be isch-
emic cell injury to the spinal cord. The neurologic deficits
caused by SCI after aortic surgery can be conceptualized as
varying on three major axes: location, severity, and time to
onset/resolution. With rare exceptions,21 the location
(termed proximity) of the deficit is limited to the lower
extremity or lower trunk musculature. In addition, the
deficit can be left-side predominant, right-side predomi-
nant, or symmetric. Vertical location can also differ when
the deficit does not cover the entire lower extremity. The
severity of deficit ranges from minor weakness to total
paralysis. In addition to motor deficits, sensory deficits,
neuropathic pain, and bowel/bladder dysfunction have
also been observed.11,12
Crawford classified the severity of the SCI deficit as
paraplegia (defined as minimal function) and paraparesis
(patient had motion against resistance or gravity across all
Fig 1. Kaplan-Meier estimate for survival of patients after tho-
racic aneurysm and thoracoabdominal aneurysm repair stratified by
all patients who presented spinal cord ischemia (SCI, dashed line)
and those who did not (dotted line). P value determined by
Mantel-Cox long-rank univariate analysis.
0-1 Year 2-3 Years 4-5 Years
All SCI
At risk 64 23 24
% Survival (SE) 52 (6) 45 (5) 25 (6)
No SCI
At risk 509 271 193
% Survival (SE) 73 (2) 62 (2) 51 (3)joints).1 Since this description, several measures of severity
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animal models of spinal cord damage,22,23 but the dichotic
classification of paraplegia and paraparesis continues to be
used in the surgical literature. The international standards
for neurologic classification of spinal cord injury were es-
tablished by the ASIA to provide a uniform method of
comparison of neurologic deficit after SCI.24 This involves
evaluating patients with a 5-point scale and categorizing
neurologic deficit according to nine different variables that
are often confusing because motor deficits differ between
upper and lower extremities.24 The SCID scale was created
to stratify patients into clinically useful categories without
being too complex to reproduce. Patients with partial def-
icits after SCI often have varied motor function across
different muscle groups, and the SCID classification takes
this into account because the grade from each muscle
group is averaged to create the total score.
One issue that confounds the stratification of SCI after
TAA repair is the timing of the initial neurologic examina-
tion. A subset of patients initially presented with flaccid
paralysis (SCID I) but experienced symptomatic improve-
ment with the prompt institution of neuroprotective ther-
apy. This includes transfer to an ICU setting, pharmaco-
logic elevation of the blood pressure, and the institution of
spinal drainage to increase the spinal cord perfusion pres-
sure. Although our neurologists are involved early when
SCI is expected, the logistics of implementing the above
therapy can delay the initial extended neurologic examina-
Fig 2. Kaplan-Meier estimate for survival of patients after tho-
racic aneurysm and thoracoabdominal aneurysm repair stratified by
spinal cord ischemia deficit I (SCID I, dot-dash line) and SCID II
and III (solid line). P value determined by Mantel-Cox long-rank
univariate analysis.
0-1 Year 2-3 Years 4-5 Years
SCID I
At risk, No. 24 3 1
% Survival (SE) 21 (8) 13 (8) 0 (0)
SCID II/III
At risk, No. 40 20 13
% Survival (SE) 73 (7) 66 (8) 41 (10)tion, at which time patients may have already experienced adegree of neurologic recovery. This may also explain why
no patients with SCID I deficits were ambulatory at the
time of follow-up, because patients who are going to re-
cover will usually show some early sign of improvement
with the initiation of therapy.
Much has been written about the use of neuroprotec-
tive adjuncts in the prevention of SCI after TA/TAA
repair.5-7 Indeed, the adoption of this posture has signifi-
cantly reduced the rate of SCI in our patients, especially
those with type I to III TAA.7 The role played by neuro-
protective adjuncts in the determination of deficit severity
has been previously reported.25 Our finding that a signifi-
cantly higher percentage of patients with SCID II and III
deficits had received spinal drainage and epidural cooling
compared with those with flaccid paralysis (SCID I) sup-
ports the continued use of neuroprotective adjuncts in
anatomically high-risk patients.
Renal insufficiency has been described as a risk factor
for early neurologic deficit10 but was not predictive of SCI
in our recent series.7 Despite this, the finding that renal
insufficiency is significantly higher in patients with flaccid
paralysis is not surprising. This may be the result of added
difficulty inmanaging volume status in patients who are not
producing urine or could reflect patients who were hemo-
dynamically unstable. Previous series have noted a protec-
tive effect of female sex against neurologic deficit,10 but
again, this has not been true in our recent experience.7 In
the current cohort, however, male sex was significantly
associated with flaccid paralysis. A univariate analysis of the
available variables stratified for sex revealed no confound-
ing relationships, so the reason for this association is un-
clear.
Crawford noted a 30-day mortality of 23% in patients
who developed paraplegia vs 9% in those with paraparesis.1
Our mortality rate was twice as high in patients with flaccid
paralysis (46%). This may be related to quality of life issues,
because families of patients who developed a SCID I deficit
that did not improve were more likely to withdraw care.
Despite this phenomenon, there is no doubt that patients
with SCID I paralysis experience a greater number of
additional complications that increase their risk of early
death. Comparatively, the 30-day mortality of SCID III
patients was 0%, reflecting a more vital cohort of patients.
This is further reflected in the long-term survival outcomes
(Fig 2), where patients with SCID II and III lesions have a
survival similar to those with no SCI, whereas all patients
with SCID I deficits were dead at 5 years.
One metric used to determine the validity of any neu-
rologic grading scale is its correlation with functional out-
comes.24 Admittedly, it would have been impossible to
compare outcomes in these patients with standard quality
of life measures such as questionnaires because all patients
in SCID I group died. Instead, we used survival and ambu-
latory status as our desired outcomes. Both metrics appear
to validate the SCID scale, because mortality rates and
ambulatory status improved as neurologic deficit, as de-
fined by the SCID scale, became less severe.
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important advancement in the repair of TAs to date, and
emerging technologies will allow this procedure to eventu-
ally be applied to patients with TAA.26-28 Our experience
with SCI after TEVAR is small, and no real conclusions can
be made from a sample size of seven.27 However, it is
interesting that the distribution of SCI between SCID I
and SCID II and III was very similar in this group, and
most presented in a delayed fashion. This is similar to recent
reports involving the TAG device (W. L. Gore and Assoc,
Flagstaff, Ariz), where most incidents of SCI were delayed
and resolved or improved with therapy.13,29 These obser-
vations have led to our adoption of the practice of observ-
ing our TEVAR patients in an ICU setting with continuous
arterial pressure monitoring for 48 hours to prevent sudden
changes in blood pressure that can precipitate neurologic
events.
CONCLUSION
Despite advances in operative technique and the appli-
cation of various neuroprotective adjuncts, SCI remains a
significant complication of the repair of aneurysms of the
thoracic aorta. Patient survival and functional outcome
after SCI are directly linked to deficit severity, and the
application of a classification system similar to the SCID
score can provide prognostic information for patients and
their families during the initial postoperative period. These
data underscore the importance of early and aggressive
intervention when SCI is expected after TA/TAA repair,
because early improvement to SCID II or III from flaccid
paralysis has significant implications for survival and func-
tional status.
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